Typhoid fever: Continuing challenges from a resilient bacterial foe;La fievre typhoide: Defi continuel d'un adversaire bacterien resistant

Bulletin de l'Institut Pasteur

Volumn 95, Issue 3, 1997, Pages 129-142

  Ivanoff, B ^a   Levine, M M ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; DIARRHEA; FOOD HANDLING; HAND WASHING; HYGIENE; INFECTION CONTROL; REVIEW; SALMONELLA TYPHI; SANITATION; TYPHOID FEVER; WATER MANAGEMENT; WATER SUPPLY;

BACTERIA (MICROORGANISMS); SALMONELLA TYPHI;

EID: 0030839555     PISSN: 00202452     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-2452(97)81367-X     Document Type: Review

References (100)

1. Osler, W. (1982), Typhoid fever, in "The principles and practice of medicine" (Osler, W.) (pp. 2-43). New York, D Appleton.
2. Woodward, T.E., Smadel, J.E., Ley, H.L., Green, R. & Mankakan, D.S. (1948), Preliminary report on the beneficial effect of choloromycetin in the treatment of typhoid fever. Ann. Intern. Med., 29, 131-134.
3. Gupta, A. (1994), Multidrug-resistant typhoid fever in children: epidemiology and therapeutic approach. Pediatr. Infect. Dis., 13, 124-140.
4. Bhutta, Z.A., Naqvi, S.H., Razzaq, R.A. & Farooqui, B.J. (1991), Multidrug-resistant typhoid in children: presentation and clinical features. Rev. Infect. Dis., 13, 832-836.
5. JAMA (1920), Typhoid in the large cities of the United States in 1919. JAMA, 672-675.
6. Wolman, A. & Gorman, A. (1931), The significance of waterborne typhoid fever outbreaks. Baltimore, Williams & Wilkins.
7. Ames, W. & Robins, M. (1943), Age and sex as factors in the development of the typhoid carrier state and a method of estimating carrier prelavence. Am. J. Public Health, 33, 221-230.
8. Gray, A.L. (1938), The probable typhoid carrier incidence in Mississippi. Am. J. Publ. Health, 28, 1415-1419.
9. Edelman, R. & Levine, M.M. (1986), Summary of an international workshop on typhoid fever. Rev. Infect. Dis., 8, 329-349.
10. Pfeiffer, R. & Kolle, W. (1896), Experimentelle Untersuchunger zur Frage der Schutzimpfung des Menschen gegen Typhus abdominalis. Dtsch. Med. Wocheschr., 22, 735-737.
11. Wright, A.E. & Semple, D. (1897), Remarks on vaccination against typhoid fever. Br. Med. J., 1, 256-258.
12. Polish Typhoid Committee (1966), Controlled field trial and laboratory studies on the effectiveness of typhoid vaccines in Poland 1961-64. Bull. WHO, 34, 211-222.
13. Ashcroft, M.T., Nicholson, C.C., Balwant, S., Ritchie, J.M., Sorvan, E. & William, F. (1967), A sevenyear field trial of two typhoid vaccines in Guiana. Lancet, 2, 1056-1060.
14. Yugoslav Typhoid Commission (1964), A controlled field trial of the effectiveness of acetone-dried and inactivated and heat-phenol-inactivated typhoid vaccines in Yugoslavia. Bull. WHO, 30, 623-630.
15. Olarte, J. & De la Torre, J.A. (1959), Resistance of Shigella flexneri to tetracyclines, chloramphenicol and streptomycin. Am. J. Trop. Med. Hyg., 8, 324-326.
16. Mitsuhashi, S. (1969), The R factors. J. Infect. Dis., 119, 89-100.
17. Olarte, J. & Galindo, E. (1973), Salmonella typhi resistant to chloramphenicol, ampicillin, and other antimicrobial agents : strains isolated during an extensive typhoid fever epidemic in Mexico. Antimicrob. Agents Chemother., 4, 597-601.
18. Gilman, R.H., Terminel, M., Levine, M.M., Hernandez Mendosa, P., Calderone, E., Vasquez, V., Martinez, E., Snyder, M.J. & Hornick, R.B. (1975), Comparison of trimethoprim-sulfamethoxazole and amoxicillin in therapy of chloramphenicol-resistant and chloramphenicol-sensitive typhoid fever. J. Infect. Dis., 132, 630-636.
19. Yi, A., Garcia, M., Llanos, A., Guerra, J. & Gotuzzo, E. (1981), Emergencia de resistencia al cloranfenicol en Salmonella typhi in vivo e in vitro en el curso de una epidemia. Diagnostico, 8, 87-93.
20. Goldstein, F.W., Chumpitaz, J.C., Guevara, J.M., Papadopoulou, B., Acar, J.F. & Vieu, J.F. (1986), Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi. J. Infect Dis., 153, 261-266.
21. Butler, T., Linh, N.N., Arnold, K. & Pollack, M. (1973), Chloramphenicol-resistant typhoid fever in Vietnam associated with R factor. Lancet, 2, 983-985.
22. Ricosse, J.H., Goudineau, J.A., Doury, J.C., Vieu, J.F., Meyruey, M.H. & Pelloux, H. (1979), Typhoid fever in Vietnam. - I. Bacteriological study (607 Salmonella strains isolated from 1961 to 1975 at the Grall Hospital of Saigon). Med. Trop., 39, 415-424.
23. Rowe, B., Ward, L.R. & Threlfall, E.J. (1990), Spread of multiresistant Salmonella typhi. Lancet, 336, 1065-1066.
24. Mikhail, I.A., Haberberger, R.L., Farid, Z., Girgis, N.I. & Woody, J.N. (1989), Antibiotic-multiresistant Salmonella typhi in Egypt. Trans. R. Soc. Trop. Med. Hyg., 83, 120.
25. Anand, A.C., Kataria, V.K., Singh, W. & Chatterjee, S.K. (1990), Epidemic multiresistant enteric fever in eastern India (letter). Lancet, 335, 352.
26. Nguyen, T.A., Ha Ba, K. & Nguyen, T.D. (1993), Typhoid fever in South Vietnam, 1990-1993. Bull. Soc. Pathol. Exot., 86, 476-478.
27. Vinh, H., Wain, J., Vo, T.N., Cao, N.N., Mai, T.C., Bethell, D., Nguyen, T.T., Tu, S.D., Nguyen, M.D. & White, N.J. (1996), Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children. Antimicrob. Agents Chemother., 40, 958-961.
28. Singh, M. (1991), The challenge of multi-drug resistant typhoid fever (editorial). Indian Pediatr., 28, 329-332.
29. Bhutta, Z.A. (1996), Impact of age and drug resistance on mortality in typhoid fever. Arch. Dis. Child., 75, 214-217.
30. Institute of Medicine (1985), New Vaccine Development. Establishing Priorities, Volume II. Diseases of Importance in Developing Countries. National Academy Press, Washington, D.C.
31. Mahle, W.T. & Levine, M.M. (1993), Salmonella typhi infection in children younger than five years of age. Pediatr. Infect. Dis. J., 12, 627-631.
32. Ferreccio, C., Levine, M.M., Manterola, A., Rodriguez, G., Rivara, I., Prenzel, I., Black, R.E., Mancuso, T. & Bulas, D. (1984), Benign bacteremia caused by Salmonella typhi and paratyphi in children younger than 2 years. J. Pediatr., 104, 899-901.
33. Rubin, P.A., Kopecko, D.J., Sack, R.B., Sudarmono, P., Yi, A., Maurta, D., Meza, R., Moechtar, M.A., Edman, D.C. & Hoffman, S.L. (1988), Evaluation of a DNA probe for identifying Salmonella typhi in Peruvian and Indonesian bacterial isolates. J. Infect Dis., 157, 1051-1053.
34. Song, J.H., Cho, H., Park, M.Y., Na, D.S. & Moon, H.B. (1993), Detection of Salmonella typhi in the blood of patients with typhoid fever by polymerase chain reaction. J. Clin. Microbiol., 31, 1439-1443.
35. Zhu, Q., Lim, C.K. & Chan, Y.N. (1996), Detection of Salmonella typhi by polymerase chain reaction. J. Appl. Bacterial., 80, 244-251.
36. Sivadasan, K., Kurien, B. & John, T.J. (1984), Rapid diagnosis of typhoid fever by antigen detection. Lancet, 1, 134-135.
37. Murray, B.E., Levine, M.M., Cordano, A.M., D'Ottone, K., Jayanetra, P., Kopecko, D., Pan-Urae, R. & Prenzel, I. (1985), Survey of plasmids in Salmonella typhi from Chile and Thailand. J. Infect. Dis., 151, 551-555.
38. Whiteley, M. & Taylor, D.E. (1983), Identification of DNA homologies among H incompatibility group plasmids by restriction enzyme digestion and Southern transfer hybridization. Antimicrob. Agents Chemother., 24, 194-200.
39. Chabbert, Y.A. & Gerbaud, G.R. (1974), Epidemiological surveillance of plasmids mediating resistance to chloramphenicol, in "Salmonella typhi" (author's transl). Ann. Microbiol. (Paris), 125A, 153-166.
40. Ling, J. & Chau, P.Y. (1984), Plasmids mediating resistance to chloramphenicol, trimethoprim, and ampicillin in Salmonella typhi strains isolated in the Southeast Asian region. J. Infect Dis., 149, 652.
41. Anderson, E.S. & Smith, H.R. (1972), Chloramphenicol resistance in the typhoid bacillus. Br. Med. J., 3, 329-331.
42. Anderson, E.S. (1975), The problem and implications of chloramphenicol resistance in the typhoid bacillus. J. Hyg. (Lond.), 74, 289-299.
43. Hermans, P.W., Saha, S.K., van Leeuwen, W.J., Verbrugh, H.A., van Belkum, A. & Goessens, W.H. (1996), Molecular typing of Salmonella typhi strains from Dhaka (Bangladesh) and development of DNA probes identifying plasmid-encoded multidrug-resistant isolates. J. Clin. Microbiol., 34, 1373-1379.
44. Rowe, B., Ward, L.R. & Threlfall, E.J. (1997), Mul-tidrug-resistant Salmonella typhi: a worldwide epidemic. Clin. Infect. Dis., 24 Suppl. l, S106-S109.
45. Gaines, S., Sprinz, H., Tully, J. & Tigertt, W. (1968), Studies on infection and immunity in experimental typhoid fever. - VII. The distribution of Salmonella typhi in chimpanzee tissue following oral challenge and the relationship between the numbers of bacilli and morphologic lesions. J. Exp. Med., 118, 293-306.
46. Edsall, G., Gaines, S., Landy, M., Tigertt, W., Sprinz, H., Trapani, R., Mandes, A. & Benenson, A. (1960), Studies on infection and immunity in experimental typhoid fever. J. Exp. Med., 112, 143-166.
47. Ivanoff, B., Martel, J.L., Hiret, D., Parado, C., Normier, G. et al. (1980), Etude chez le veau de l'infection expérimentale par Salmonella tiphymurium: rôle protecteur d'extraits ribosomaux homologues. Ann. Microbiol./lnst. Pasteur, 131 B, 163-174.
48. Robertsson, J.A., Lindberg, A.A., Hoiseth, S. & Stocker, B.A.D. (1983), Salmonella typhimurium infection in calves : protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines. Infect. Immun., 41, 742-750.
49. Ivanoff, B., Cordel, J., Robert, D. & Fontanges, R. (1980), Importance de la voie respiratoire dans la salmonellose expérimentale de la souris Balb/c. C.R. Acad. Sci., 1271-1274.
50. Hsu, H.S. (1989), Pathogenesis and immunity in murine salmonellosis. Microbiol. Rev., 53, 390-409.
51. Liu, S.L. & Sanderson, K.E. (1995), Genomic cleavage map of Salmonella typhi Ty2. J. Bacteriol., 177, 5099-5107.
52. Liu, S.L. & Sanderson, K.E. (1996), Highly plastic chromosomal organization in Salmonella typhi. Proc. Natl. Acad. Sci. USA, 93, 10303-10308.
53. Germanier, R. & Purer, E. (1975), Isolation and characterization of gal E mutant Ty21a of Salmonella typhi: A candidate strain for a live oral typhoid vaccine. J. Infect. Dis., 141, 553-558.
54. Wahdan, M.H., Serie, C., Cerisier, Y., Sallam, S. & Germanier, R. (1982), A controlled field trial of live Salmonella typhi strain Ty21a oral vaccine against typhoid: Three year results. J. Infect. Dis., 145, 292-296.
55. Levine, M.M., Ferreccio, C., Cryz, S. & Ortiz, E. (1990), Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial. Lancet, 336, 891-894.
56. Simanjuntak, C., Paleologo, F., Punjabi, N., Darmowitogo, R., Soeprawato, Totosudirjo, H., Haryanto, P., Suprijanto, E., Witham, N. & Hoffman, S.L. (1991), Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet, 338, 1055-1059.
57. Robbins, J. & Robbins, J. (1984), Reexamination of the protective role of the capsular polysaccharide Vi antigen of Salmonella tvphi. J. Infect. Dis., 150, 436-449.
58. Levin, D.M., Wong, K.H., Reynolds, H.Y., Sutton, A. & Northrup, R. (1975), Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans. Infect. Immun., 12, 1290-1294.
59. Wong, K.H., Feeley, J.C., Northrup, R.S. & Forlines, M.E. (1974), Vi antigen from Salmonella typhosa and immunity against typhoid fever. - I. Isolation and immunologie properties in animals. Infect. Immun., 9, 348-353.
60. Acharya, V.l., Lowe, C.U., Thapa, R., Gurubacharya, V.L., Shrestha, M.B., Cadoz, M., Schulz, D., Armand, J., Bryla, D.A., Trollfors, B., Cramton, T., Schneerson, R. & Robbins, J.B. (1987), Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N. Engl. J. Med., 317, 1101-1104.
61. Klugman, K., Gilbertson, I.T., Kornhoff, H.J. et al. (1987), Protective activity of Vi polysaccharide vaccine against typhoid fever. Lancet, 2, 1165-1169.
62. Ryan, C.A., Hargrett-Bean, N.T. & Blake, P.A. (1989), Salmonella typhi infections in the United States, 1975-1984: Increasing role of foreign travel. Rev. Infect. Dis., II, 1-8.
63. Taylor, D.N., Pollard, R.A. & Blake, P.A. (1983), Typhoid in the United States and risk to the international traveler. J. Infect. Dis., 148, 599-602.
64. Rice, P.A., Baine, W.B. & Gangarosa, E.J. (1977), Salmonella typhi infections in the United States, 1967-1972: Increasing importance of international travelers. Am. J. Epidemiol, 106, 160-166.
65. Blaser, M.J. & Feldman, R.A. (1980), Acquisition of typhoid fever from proficiency-testing specimens. (Correspondence). JAMA, 303, 1481-1482.
66. Blaser, M.J., Hickman, F.W., Farmer, J.J., Brenner, D.J., Ballows, A. & Feldman, R.A. (1980), Salmonella typhi: The laboratory as a reservoir of infection. J. Infect. Dis., 142, 934-938.
67. Ivanoff, B., Levine, M.M. & Lambert, P.H. (1994), Vaccination against typhoid fever: present status. Bull. WHO, 72, 957-971.
68. Levine, M.M. (1994), Typhoid fever vaccines, in "Vaccines, 2nd Ed." (Plotkin, S.A. and Mortimer, E., Jr.). Philadelphia, W.B. Saunders.
69. Levine, M.M., Ferreccio, C., Black, R.E., Tacket, C.O. & Germanier, R. (1989), Progress in vaccines against typhoid fever. Rev. Infect. Dis., 11 Suppl. 3, S552-S567.
70. Levine, M.M., Taylor, D.N. & Ferreccio, C. (1989), Typhoid vaccines come of age. Pediatr. Infect. Dis. J., 8, 374-381.
71. Ferreccio, C., Levine, M.M., Rodriguez, H. & Contreras, R. (1989), Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules : a field trial in an endemic area. J. Infect. Dis., 159, 766-769.
72. Cryz, S.J.J., Vanprapar, N., Thisyakorn, U., Olanratmanee, T., Losonsky, G., Levine, M.M. & Chearskul, S. (1993), Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children. Infect. Immun., 61, 1149-1151.
73. Plotkin, S.A. & Bouveret-Le Cam, N. (1995), A new typhoid vaccine composed of the Vi capsular polysaccharide. Arch. Intern. Med., 155, 2293-2299.
74. Szu, S.C., Stone, A.L., Robbins, J.D., Schneerson, R. & Robbins, J.B. (1987), Vi capsular polysaccharideprotein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals. J. Exp. Med., 166, 1510-1524.
75. Szu, S.C., Li, X., Schneerson, R., Vickers, J.H., Bryla, D. & Robbins, J.B. (1989), Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subu-nit as a carrier bound to high-or low-molecular weight-Vi. Infect. Immun., 57, 3823-3827.
76. Szu, S.C., Taylor, D.N., Trofa, A.C., Clements, J.D., Shiloach, J., Sadoff, J.C., Bryla, D.A. & Robbins, J.B. (1994), Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines. Infect. Immun., 62, 4440-4444.
77. Tacket, C.O., Hone, D.M., Losonsky, G.A., Guers, L., Edelman, R. & Levine, M.M. (1992b), Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain. Vaccine, 10, 443-446.
78. Levine, M.M., Tacket, C.O., Galen, J.E., Barry, E.M., Chatfield, S.N., Dougan, G., Noriega, F. & Sztein, M.B. (1997), Progress in development of new attenuated strains of Salmonella typhi as live oral vaccines, in "New generation vaccines, second Ed." (Levine, M.M., Woodrow, G.C., Kaper, J.B., and Cobon, G.S.). Marcel Dekker, New York.
79. Kantele, A. (1990), Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. Vaccine, 8, 321-326.
80. Sztein, M., Tanner, M.K., Polotsky, Y., Orenstein, J.M. & Levine, M.M. (1995), Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. J. Immunol., 155, 3987-3993.
81. Sztein, M.B., Wasserman, S.S., Tacket, C.O., Edelman, R., Hone, D., Lindberg, A.A. & Levine, M.M. (1994), Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J. Infect. Dis., 170, 1508-1517.
82. Chatfield, S.N., Strahan, K., Pickard, D., Charles, I.G., Hormaeche, C.E. & Dougan, G. (1992), Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb. Pathog., 12, 145-151.
83. Levine, M.M., Galen, J., Barry, E., Noriega, F., Chatfield, S., Sztein, M., Dougan, G. & Tacket, C. (1995), Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors. J. Biotechnol., 44, 193-196.
84. Tacket, C.O., Sztein, M.B., Losonsky, G.A., Wasserman, S.S., Nataro, J.P., Edelman, R., Pickard, D., Dougan, G., Chatfield, S.N. & Levine, M.M. (1997), Safety and immune response in humans of live oral Salmonella typhi vaccine strains deleted in htrA and aroC, aroD. Infect. Immun., 65, 452-456.
85. Curtiss, R., III & Kelly, S.M. (1987), Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun., 55, 3035-3043.
86. Curtiss, R., III, Kelly, S.M., Tinge, S.A., Tacket, C.O., Levine, M.M., Srinivasan, J. & Koopman, M. (1994), Recombinant Salmonella vectors in vaccine development. Dev. Biol Stand., 82, 23-33.
87. Tacket, CO., Hone, D.M., Curtiss, R.I., Kelly, S.M., Losonsky, G., Guers, L., Harris, A.M., Edelman, R. & Levine, M.M. (1992), Comparison of the safety and immunogenicity of aroC, aroD and cya,crp Salmonella typhi strains in adult volunteers. Infect. Immun., 60, 536-541.
88. Tacket, C.O., Kelly, S.M., Schodel, F., Losonsky, G., Nataro, J.P., Edelman, R., Levine, M.M. & Curtiss, R., III (1997), Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the ASD balanced lethal system. Infect. Immun, (in press).
89. Hohmann, E.L., Oletta, C.A. & Miller, S.L. (1996), Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine, 14, 19-24.
90. Hohmann, E.L., Oletta, C.A., Killeen, K.P. & Miller, S.I. (1996), phoP/phoQ-deleted Salmonella typhi (Ty8OO) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J. Infect. Dis., 173, 1408-1414.
91. Bodhidatta, L., Taylor, D.N., Thisyakorn, U. & Echeverria, P. (1987), Control of typhoid fever in Bangkok, Thailand, by annual immunization of school children with parenteral typhoid fever. Rev. Infect. Dis., 9, 841-845.
92. Black, R.E., Levine, M.M., Ferreccio, C, Clements, M.L., Lanata, C., Rooney, J. & Germanier, R. (1990), Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee. Vaccine, 8, 81-84.
93. Chuttani, C.S., Prakash, K., Vergese, A., Sharma, U., Shinga, P. & Ghosh, R.B. (1971), Effectiveness of oral killed typhoid vaccine. Bull. WHO, 45, 445-450.
94. Chuttani, C.S., Prakash, K., Vergese, A. et al. (1973), Ineffectiveness of an oral killed typhoid vaccine in a field trial. Bull. WHO, 48, 756-757.
95. Chuttani, C.S. (1976), Controlled field trials of three different oral killed typhoid vaccines in India. Dev. Biol. Stand., 33, 98-101.
96. Chuttani, D.S., Prakash, K., Gupta, P., Graven, V. & Kumar, A. (1977), Controlled field trial of a high dose oral killed typhoid vaccine in India. Bull. WHO, 55, 643-644.
97. Hejfec, L.B., Salmin, L.V., Lejtman, M.Z., Kuzminova, M.L., Vasileva, A.V., Levina, L.A., Bencianova, T.G., Pavlova, E.A. & Antonova, A.A. (1966), A controlled field trial and laboratory study of five typhoid vaccines in the USSR. Bull. WHO, 34, 321-339.
98. Levine, M.M., Ferreccio, C., Black, R.E., Germanier, R. & Chilean Typhoid Committee (1987), Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet, 1, 1049-1052.
99. Tapa, S. & Cvjetanovic, B. (1975), Controlled field trial on the effectiveness of one and two doses of acetone-inactivated and dried typhoid vaccine. Bull. WHO, 52, 75-80.
100. Wahdan, M.H., Sippel, J.E. & Mikhail, I.A. et al. (1975), Controlled field trial of a typhoid vaccine prepared with non-motile mutant of Salmonella typhi Ty2. Bull. WHO, 52, 69-73.